Position in A
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$218,903
-$139,450 QoQ
Shares Held
1,648
-47.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#827
of 1,120 holders
Holding Since
Mar 2021
13 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in A Over Time
Shares Held
Position Value (USD)
Derivatives in A
reported options exposure · as of Jun 30, 2026CallValue
$531,320
CallShares
4,000
PutValue
$531,320
PutShares
4,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Centiva Capital, LP holds $3,725,083 across 4 Diagnostics & Research names. A ranks #2 (5.9% of the industry book) .
All Filings in A
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $531,320 | 4,000 | Put | Sole | 2026-08-13 | |
| 2026-06-30 | $531,320 | 4,000 | Call | Sole | 2026-08-13 | |
| 2026-06-30 | $218,903 | 1,648 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $358,353 | 3,144 | Shares | Sole | 2026-05-14 | |
| 2025-06-30 | $769,189 | 6,518 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,634,630 | 39,619 | Shares | Sole | 2025-05-15 | |
| 2024-06-30 | $2,711,470 | 20,917 | Shares | Sole | 2024-08-14 | |
| 2023-09-30 | $412,392 | 3,688 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $572,510 | 4,761 | Shares | Sole | 2023-08-14 | |
| 2022-12-31 | $239,440 | 1,600 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $1,008,378 | 8,296 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $731,652 | 5,529 | Shares | Sole | 2022-05-16 | |
| 2021-09-30 | $455,419 | 2,891 | Shares | Sole | 2021-11-17 | |
| 2021-06-30 | $676,082 | 4,574 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $686,301 | 5,398 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||